Send to a Friend Font Size: Increase Decrease

6938 and MDGL Related Headlines

Jul 1, 2026 09:19PM Ribo and Madrigal Reach First Major Milestone in Advancing Novel siRNA Therapies for MASH
Feb 11, 2026 06:25AM Ribo and Ribocure Announce Exclusive Global Licensing Agreement with Madrigal for Novel siRNA Therapeutics Targeting MASH

6938 and MDGL Related Press Releases

Jul 1, 2026 09:19PM Ribo and Madrigal Reach First Major Milestone in Advancing Novel siRNA Therapies for MASH
Feb 11, 2026 06:25AM Ribo and Ribocure Announce Exclusive Global Licensing Agreement with Madrigal for Novel siRNA Therapeutics Targeting MASH

6938 and MDGL Related SEC Filings